Cyberounds Logo
August 11, 2020 | LOGIN | REGISTER | HELP | 


email a friend print Bookmark and Share
Optimal Treatment for Hypertension in Patients at Risk for Cardiovascular Disease: A New Perspective
CME credit is no longer available for this conference.
Frank A. Laws, M.D., and Richard W. Smalling, M.D., Ph.D.

Dr. Laws is from the Division of Cardiology, Department of Medicine, The University of Texas Medical School at Houston and Memorial Hermann Hospital, Houston, Texas.

During the past three years, Dr. Smalling has received grant/research support from Centocor, Cordis, Boston Scientific and Merck. Dr. Laws reports no commercial conflict of interest.

This activity is made possible by an unrestricted educational grant from Pfizer


Release Date: 12/26/2001
Termination Date: 12/26/2004

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Identity which parameter of blood pressure yields the best prognostic information in hypertensive patients at risk for cardiovascular disease
  • Identify the blood pressure profiles that represent the best therapeutic goals in hypertensive patients who are at risk for the development of cardiovascular disease
  • Discuss why evaluation of other indices of arterial load and stiffness can lead to the early identification and treatment of patients at risk for the development of cardiovascular disease.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity